For individuals, friends and families who are looking to connect during life's challenging times. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.
Sponsored Links
Main Menu
Community
Treatment
Understand
- Where to Start
- What is Lymphoma?
- The Lymphatic System
- Lymphoma Symptoms
- Lymphoma Causes
- Lymphoma Prognosis
- Refractory/Relapsed Lymphoma
Non-Hodgkin's Lymphoma
Hodgkin's Disease
Surviving Lymphoma
Lymphoma and Pets
More
NCI's Featured Clinical Trial involves patients with DLBCL
-
Call (877) 399-6937 or click here to learn more about Cancer Treatment options.
The National Cancer Institute's Featured Clinical Trial concerns patients with Diffuse Large B-Cell Non-Hodgkin Lymphoma.
Trial Name
Phase III Randomized Study of Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) Versus Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin and Rituximab (EPOCH-R) in Patients with Previously Untreated De Novo Diffuse Large B-Cell Non-Hodgkin Lymphoma (CALGB-50303).
Trial focus
Patients with previously untreated Diffuse large B-cell lymphoma (DLBCL) will be randomly assigned to receive either R-CHOP or EPOCH-R for 6 to 8 cycles. NCI researchers believe that there may be three different subtypes of DLBCL that have varying patterns of gene expression.
Endpoints
- "Can EPOCH-R produce better clinical outcomes than R-CHOP for patients with DLBCL?"
- "Can we use gene expression profiling to determine prognostic molecular characteristics that will tell us which patients benefit most from these different regimens?”
Additional Information
- Entry criteria
- Trial contact information
- NCI's Cancer Information Service (toll-free and confidential): 1-800-4-CANCER (1-800-422-6237).
-
Call (877) 399-6937 or click here to learn more about Cancer Treatment options.
Support Groups
Find a Treatment Facility Near You
Click on a state below to find Lymphoma treatment options that could be right for you.
Select a State Below
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.
Sponsored Links
LymphomaInfo Social
SupportGroups.com
SupportGroups.com provides a support network for those dealing with cancer and other life's challenges. Click on the following links to get the support in a confidential, caring environment.
Follow LymphomaInfo.net on:
Facebook:
Twitter: